The Reporting of A Disproportionality analysis for drUg Safety signal detection using spontaneously reported adverse events in PharmacoVigilance (READUS-PV)

被引：0
|
作者：
Fusaroli, M. [1 ]
Raschi, E. [1 ]
Salvo, F. [2 ]
Khouri, C. [3 ]
机构：
[1] Univ Bologna, Dept Med & Surg Sci, Pharmacol Unit, Bologna, Italy
[2] CHU Bordeaux, Serv Pharmacol Med, Bordeaux, France
[3] Grenoble Alpes Univ Hosp, Pharmacovigilance Unit, Grenoble, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2023年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
CO-060
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [1] Guidelines for the Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in Pharmacovigilance (READUS-PV)
    Fusaroli, Michele
    Salvo, Francesco
    Raschi, Emanuel
    Khouri, Charles
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 545 - 546
  • [2] The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement
    Fusaroli, Michele
    Salvo, Francesco
    Begaud, Bernard
    Alshammari, Thamir M.
    Bate, Andrew
    Battini, Vera
    Brueckner, Andreas
    Candore, Gianmario
    Carnovale, Carla
    Crisafulli, Salvatore
    Cutroneo, Paola Maria
    Dolladille, Charles
    Drici, Milou-Daniel
    Faillie, Jean-Luc
    Goldman, Adam
    Hauben, Manfred
    Herdeiro, Maria Teresa
    Mahaux, Olivia
    Manlik, Katrin
    Montastruc, Francois
    Noguchi, Yoshihiro
    Noren, G. Niklas
    Noseda, Roberta
    Onakpoya, Igho J.
    Pariente, Antoine
    Poluzzi, Elisabetta
    Salem, Myriam
    Sartori, Daniele
    Trinh, Nhung T. H.
    Tuccori, Marco
    van Hunsel, Florence
    van Puijenbroek, Eugene
    Raschi, Emanuel
    Khouri, Charles
    DRUG SAFETY, 2024, 47 (06) : 575 - 584
  • [3] The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration
    Fusaroli, Michele
    Salvo, Francesco
    Begaud, Bernard
    Alshammari, Thamir M.
    Bate, Andrew
    Battini, Vera
    Brueckner, Andreas
    Candore, Gianmario
    Carnovale, Carla
    Crisafulli, Salvatore
    Cutroneo, Paola Maria
    Dolladille, Charles
    Drici, Milou-Daniel
    Faillie, Jean-Luc
    Goldman, Adam
    Hauben, Manfred
    Herdeiro, Maria Teresa
    Mahaux, Olivia
    Manlik, Katrin
    Montastruc, Francois
    Noguchi, Yoshihiro
    Noren, G. Niklas
    Noseda, Roberta
    Onakpoya, Igho J.
    Pariente, Antoine
    Poluzzi, Elisabetta
    Salem, Myriam
    Sartori, Daniele
    Trinh, Nhung T. H.
    Tuccori, Marco
    van Hunsel, Florence
    van Puijenbroek, Eugene
    Raschi, Emanuel
    Khouri, Charles
    DRUG SAFETY, 2024, 47 (06) : 585 - 599
  • [4] The reporting of disproportionality analysis in pharmacovigilance: spotlight on the READUS-PV guideline
    Fusaroli, Michele
    Salvo, Francesco
    Khouri, Charles
    Raschi, Emanuel
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [5] Statistical and graphical approaches for disproportionality analysis of spontaneously-reported adverse events in pharmacovigilance
    Zink, Richard C.
    Huang Qin
    Zhang Lu-Yong
    Bao Wen-Jun
    CHINESE JOURNAL OF NATURAL MEDICINES, 2013, 11 (03) : 314 - 320
  • [6] Safety profiles of adalimumab, etanercept and infliximab: a pharmacovigilance study using a measure of disproportionality in a database of spontaneously reported adverse events
    Mendes, D.
    Alves, C.
    Batel-Marques, F.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2014, 39 (03) : 307 - 313
  • [7] DISPROPORTIONALITY ANALYSIS FOR PHARMACOVIGILANCE OF MEDICAL DEVICE RELATED ADVERSE EVENTS REPORTED TO THE FDA
    Duggirala, H. J.
    Herz, N. D.
    Canos, D. A.
    Sullivan, R.
    Schaaf, Richard
    Pinnow, E.
    Marinac-Dabic, D.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 173 : S131 - S131
  • [8] Antibiotics-Induced Liver Injury: A Pharmacovigilance Study Using a Measure of Disproportionality in a Database of Spontaneously Reported Adverse Events
    Mendes, D.
    Dias, P.
    Alves, C.
    Batel-Marques, F.
    DRUG SAFETY, 2015, 38 (10) : 1006 - 1006
  • [9] Disproportionality analysis of reported drug adverse events to assess a potential safety signal for pentavalent vaccine in 2019 in El Salvador
    Elas, Miguel
    Villatoro, Nora
    Pezzoli, Lorenzo
    VACCINE, 2021, 39 (34) : 4849 - 4855
  • [10] A real-world pharmacovigilance study of omalizumab using disproportionality analysis in the FDA adverse drug events reporting system database
    Song, Yongfu
    Wang, Zhuang
    Wang, Na
    Xie, Xiaofei
    Zhu, Tieshi
    Wang, Yongji
    SCIENTIFIC REPORTS, 2025, 15 (01):
12345